The Centers for Medicare and Medicaid Services finalized a demonstration program aimed at lowering the prices of ...
Bristol Myers discloses a fatal liver injury in its Phase 3 program for pulmonary fibrosis drug admilparant ahead of a Q4 ...
Forget Wegovy and Zepbound. Never mind CagriSema, and even retatrutide. The latest big name in obesity is eloraTZP. Data ...
The American Biotech Innovation Alliance pressed Congress this week on US-China biotech competition, citing FDA capacity ...
Merck's tulisokibart showed mid-stage success in hidradenitis suppurativa, with 72% high-dose patients seeing 50%+ abscess ...
Varda Space Industries raises a $251M Series D, valuing it at $1.6B, to advance space-based drug manufacturing using low ...
Massachusetts is often considered the epicenter of the biotech industry because of its nucleus of world-class research institutions churning out new scientists and new startups.
NCI director Ned Sharpless as MD and Andrew Witty as chairman, while raising a $100M second opportunities fund.
Beam Therapeutics sued YolTech's Yuxuan Wu & Zi Jun Wang and Serapha Bio for allegedly stealing trade secrets related to ...
Ex-Genentech AI leaders including NYU's Kyunghyun Cho launch health startup Ortet with a $500M commitment from Matt Holt's ...
ARCH and Population Health launch Somnivera with a $10.5M-upfront deal for an ex-China sleep drug from Jiangsu Nhwa.
The cash should give the Stockholm-based biotech a runway “well into 2029,” CEO Patrik Strömberg told Endpoints News in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results